DOYLE WILLIAM F

Average Profitability
<0.0001%
Insider Buys Quantity
13
Insider Buys Sum
$722,156.92
Insider Sells Quantity
26
Insider Sells Sum
$82.25M

Insider Activity of DOYLE WILLIAM F

According to the SEC Form 4 filings, DOYLE WILLIAM F, being in a position of

  1. director at Elanco Animal Health Incorporated,
    оver the last 12 months, has bought 30000 shares for $499,200, and sold 0 shares,
    over all time since 2024-03-08, has bought 30000 shares for $499,200, and sold 0 shares.

The largest purchase of all time was on 2024-05-21 and amounted to 15000 shares of Elanco Animal Health Incorporated for $254,700.

The largest sale of all time was on 2021-04-13 and amounted to 95000 shares of NovoCure Limited for $18.96M.

Biography of DOYLE WILLIAM F

No biography is available at this moment.

2024-05-21PurchaseElanco Animal Health Incorporated
ELAN
director
15,000
0.0031%
$16.98$254,700-12.87%
2024-03-08PurchaseElanco Animal Health Incorporated
ELAN
director
15,000
0.003%
$16.30$244,500-10.33%
2022-08-02SaleNovoCure Limited
NVCR
Executive Chairman
837
0.0008%
$69.66$58,305+6.68%
2022-03-08SaleNovoCure Limited
NVCR
Executive Chairman
2,385
0.0023%
$70.10$167,189+11.28%
2021-08-02SaleNovoCure Limited
NVCR
Executive Chairman
995
0.001%
$149.38$148,631-45.63%
2021-04-13SaleNovoCure Limited
NVCR
Executive Chairman
95,000
0.0928%
$199.55$18.96M-42.26%
2021-04-01SaleNovoCure Limited
NVCR
Executive Chairman
7,928
0.0077%
$134.12$1.06M-10.54%
2020-07-31SaleNovoCure Limited
NVCR
Executive Chairman
896
0.0009%
$76.39$68,444+107.78%
2020-05-11SaleNovoCure Limited
NVCR
Executive Chairman
31,332
0.0307%
$63.73$2M+93.65%
2020-05-08SaleNovoCure Limited
NVCR
Executive Chairman
31,903
0.0323%
$63.50$2.03M+100.87%
2020-05-07SaleNovoCure Limited
NVCR
Executive Chairman
30,993
0.0312%
$64.74$2.01M+95.49%
2020-05-06SaleNovoCure Limited
NVCR
Executive Chairman
29,881
0.0294%
$64.27$1.92M+92.25%
2020-05-05SaleNovoCure Limited
NVCR
Executive Chairman
30,283
0.0293%
$62.47$1.89M+93.76%
2020-03-06SaleNovoCure Limited
NVCR
Executive Chairman
4,320
0.0043%
$69.53$300,387+18.67%
2020-02-28SaleNovoCure Limited
NVCR
Executive Chairman
3,893
0.0039%
$72.22$281,133+9.99%
2020-01-17SaleNovoCure Limited
NVCR
Executive Chairman
133,777
0.1374%
$95.00$12.71M-14.18%
2019-11-25SaleNovoCure Limited
NVCR
Executive Chairman
16,223
0.0169%
$96.04$1.56M-14.92%
2019-11-20SaleNovoCure Limited
NVCR
Executive Chairman
150,000
0.151%
$90.36$13.55M-12.75%
2019-11-12SaleNovoCure Limited
NVCR
Executive Chairman
13,218
0.0135%
$81.68$1.08M-2.36%
2019-11-11SaleNovoCure Limited
NVCR
Executive Chairman
59,564
0.0609%
$80.11$4.77M-0.13%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.